The present invention provides novel compounds of formulas I-IX, as described herein. Also provided are compositions of compounds of formulas I-IX, methods of making compounds of formulas I-IX, and methods of using compounds of formulas I-IX. The compounds of the invention can be used to inhibit matrix metalloproteinases, and are useful to treat conditions and diseases associated therewith.

 
Web www.patentalert.com

< siRNA targeting kinase insert domain receptor (KDR)

> TRANSGENIC ORGANISM

~ 00487